These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9431556)

  • 1. Seizures and kynurenic acid--an endogenous excitatory amino acid antagonist.
    Turski WA
    Pol J Pharmacol; 1997; 49(1):66-7. PubMed ID: 9431556
    [No Abstract]   [Full Text] [Related]  

  • 2. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
    Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J
    Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid does not protect against nicotine-induced seizures in mice.
    Kiś J; Czuczwar M; Zielińska E; Bojar I; Czuczwar SJ; Turski WA
    Pol J Pharmacol; 2000; 52(6):477-80. PubMed ID: 11334243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices.
    Luchowska E; Luchowski P; Wielosz M; Turski WA; Urbanska EM
    Acta Neurobiol Exp (Wars); 2003; 63(2):101-8. PubMed ID: 12926536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stimulatory effects of intraventricular administration of kynurenines, amino acids, and convulsants: differences between rats and mice].
    Prakh'e IB; Kiseleva IP; Lapin IP
    Fiziol Zh SSSR Im I M Sechenova; 1982 Nov; 68(11):1516-21. PubMed ID: 7152052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of kynurenic acid on catecholamine content in the brain of rats with different susceptibility to seizures].
    Popova LD
    Fiziol Zh (1994); 2002; 48(6):41-5. PubMed ID: 12577468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kynurenic acid hypothesis of schizophrenia.
    Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G
    Physiol Behav; 2007 Sep; 92(1-2):203-9. PubMed ID: 17573079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.
    Chess AC; Bucci DJ
    Behav Brain Res; 2006 Jun; 170(2):326-32. PubMed ID: 16621049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
    Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of kynurenic acid on the content of excitatory and inhibitory mediators in rats with different levels of seizure susceptibility].
    Popova LD
    Ukr Biokhim Zh (1999); 2006; 78(5):120-6. PubMed ID: 17290790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons.
    Erhardt S; Oberg H; Mathé JM; Engberg G
    Amino Acids; 2001; 20(4):353-62. PubMed ID: 11452979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid.
    Knyihar-Csillik E; Mihaly A; Krisztin-Peva B; Robotka H; Szatmari I; Fulop F; Toldi J; Csillik B; Vecsei L
    Neurosci Res; 2008 Aug; 61(4):429-32. PubMed ID: 18541319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.
    Stone TW
    Eur J Neurosci; 2007 May; 25(9):2656-65. PubMed ID: 17459105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.
    Zhang DX; Williamson JM; Wu HQ; Schwarcz R; Bertram EH
    Epilepsia; 2005 Nov; 46(11):1708-15. PubMed ID: 16302850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic stimulation in the lateral septal area activates anterior hypothalamic area neurons via excitatory amino acid receptors in rats.
    Hagiwara Y; Kubo T
    Brain Res; 2005 Jul; 1049(2):203-9. PubMed ID: 15963958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.